CompoAtlas

Buzhong Yiqi Pills

Natural health product licensed in Canada

Other names
Buzhong Yiqi Wan
Licence holder
Jilin Aoyuan Medicine Technology Co. LTD.
NPN or DIN-HM
80144883
Status
Active licence
Licence date
21 October 2025
Revision date
13 November 2025
Form
Pilule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Astragalus membranaceus

Source : Astragalus membranaceus - racine

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 7,900 mg

1,580 mgNot calculated
Codonopsis tangshen

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Ziziphus jujuba

Source : Ziziphus jujuba - Fruit

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 160 mg

32 mgNot calculated
Glycyrrhiza inflata

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 3,950 mg

790 mgNot calculated
Atractylodes macrocephala

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Angelica sinensis

Source : Angelica sinensis - Racine

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Actaea heracleifolia

Source : Actaea heracleifolia - Rhizome

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Bupleurum chinense

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Citrus reticulata

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2,350 mg

470 mgNot calculated
Zingiber officinale

Source : Zingiber officinale - Rhizome

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 800 mg

160 mgNot calculated

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 8 Pilule ; maximum: 10 Pilule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Combination of Traditional Chinese Medicine Ingredients. Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80144883

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

  • Angelica sinensis
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line